Sirica Therapeutics

What Sirica Therapeutics does

Sirica Therapeutics is a privately held digital therapeutics company headquartered at 1633 Old Bayshore Hwy #127, Burlingame, California. The company is developing a platform branded "Cognitive Sensorimotor Therapy©" that integrates four therapeutic modalities — virtual reality, video gaming, advanced robotics, and physical exercise — into a single immersive environment intended to improve motor control, cognitive function, social interaction, and behavioral outcomes in children diagnosed with Autism Spectrum Disorder (ASD). The platform references academic literature supporting VR, robotic training, and aerobic exercise as interventions for neurological impairments and ASD-related symptoms, and holds a registered trademark on the "Cognitive Sensorimotor Therapy©" brand identity.

The company's principal commercial asset is the Sirica Center, a single direct patient services facility through which therapy is delivered, supplemented by a website content marketing presence (sector pages, blog/media center, newsletter). The website lists an Investor information page, but no funding rounds, investors, pricing, headcount, certifications, regulatory clearances, or revenue figures have been publicly disclosed. Leadership disclosed in the available data is limited to Founder Uli Chettipally, with no additional executive team, management roster, or board identified.

The business model and revenue mechanics are not transparent from public sources: pricing is not disclosed, no customer logos or payors are referenced, no payers/reimbursement pathway is described, and there is no indication of FDA or equivalent regulatory pathway, clinical trial activity, or third-party validation. The current operating footprint appears to be a single domestic site with no evidence of multi-site, geographic, or channel expansion.

Name

Sirica Therapeutics

Legal name

Sirica Therapeutics

Website

https://siricatherapeutics.com

Company type

Private

Operating status

Operating

Short description

Sirica Therapeutics is a private digital therapeutics company developing a Cognitive Sensorimotor Therapy© platform that integrates virtual reality, robotics, video gaming, and physical exercise to treat children with Autism Spectrum Disorder via its Sirica Center.

Ownership category

akta.pro rank

Product category

Digital Therapeutics for Autism

NAICS

Offices of Physical, Occupational and Speech Therapists, and Audiologists (621340), Services for the Elderly and Persons with Disabilities (624120), Offices of Physicians, Mental Health Specialists (621112), Other Individual and Family Services (624190)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)

akta.pro secondary industries

Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ), Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching) (HLALAEAJ), Autism Assistive Technology & Learning Tools (Educational) (EDAKAKAM), Special Needs Skill-Building & Therapy Learning Apps (Autism, OT/PT, Life Skills) (EDAFAKAJ)

Keywords

• Digital therapeutics
• Autism therapy
• Virtual reality healthcare
• Medical robotics therapy
• Pediatric rehabilitation

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels1 record

Core offering

Sirica Therapeutics develops and delivers a proprietary digital therapy, branded Cognitive Sensorimotor Therapy©, that integrates virtual reality, video gaming, advanced robotics, and physical exercise into a single immersive environment for the treatment of Autism Spectrum Disorder. Therapy sessions are delivered to patients (primarily children with ASD) through the company's Sirica Center in Burlingame, California. The platform is designed to improve motor control, cognitive function, social interaction, and behavioral outcomes while maintaining patient engagement and motivation.

Product overview

Sirica Therapeutics offers a single unified product: the COGNITIVE SENSORIMOTOR THERAPY© digital platform. This therapy integrates four component technology areas — Virtual Reality, Robotics, Physical Exercise, and Video Gaming — into a deeply immersive therapeutic environment designed to improve motor control, cognitive function, and behavioral symptoms in individuals with Autism Spectrum Disorder.

Differentiator

Problem solved

Functional benefit

Products and services

• COGNITIVE SENSORIMOTOR THERAPY© A digital therapy platform that integrates virtual reality, video gaming, advanced robotics, and physical exercise into an immersive environment for the treatment of Autism Spectrum Disorder. The therapy is delivered to patients (primarily children with ASD) at the company's Sirica Center facility in Burlingame, CA, and aims to improve motor control, cognitive function, social interaction, and behavioral outcomes.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Recent moves4 records

Expansion highlights3 records

Direct peers

• Cognoa: Cognoa is an autism-focused digital therapeutics company with FDA-cleared diagnostic SaMD (Canvas Dx) and a pipeline of ASD therapeutics. It is the most direct regulatory and clinical peer to Sirica in pediatric ASD digital therapy.
• Akili Interactive: Akili Interactive develops FDA-cleared digital therapeutics (EndeavorRx) for pediatric neurocognitive conditions including ADHD. It is a direct peer in prescription digital therapeutics for pediatric neurodevelopmental disorders.
• BehaVR: BehaVR builds VR-based digital therapeutics for mental and behavioral health. It is a direct peer given Sirica's use of VR as the primary delivery medium for behavioral/cognitive therapy.

Broad incumbents

• Saebo: Saebo is a well-established rehabilitation products company focused on upper-limb and neurological recovery devices. It is a broad incumbent in robotic/sensorimotor rehabilitation comparable to Sirica's physical rehab component.
• AppliedVR: AppliedVR is one of the more established VR-therapeutics companies (EaseVRx for chronic pain, FDA-authorized). It is a broader incumbent using VR as a clinical modality similar to Sirica.

Regional players

• Catalight: Catalight (formerly Easterseals Bay Area) is one of the largest providers of autism services across California, delivering applied behavior analysis and therapy programs. It is a regional peer serving the same California ASD population that Sirica targets.

Emerging players

• Limbic: Limbic uses VR and AI to deliver mental health therapy experiences. It is an emerging peer intersecting VR, behavioral health, and digital therapeutics.
• BrainCo: BrainCo develops neurotechnology/BCI products, including focus band wearables marketed for attention, focus, and neurofeedback applications relevant to ASD and ADHD. It overlaps with Sirica's neurocognitive therapy positioning.
• Penumbra (REAL Immersive): Penumbra's REAL System is an immersive VR rehabilitation platform used in clinical rehab settings. It is an emerging peer combining immersive VR with physical/sensorimotor therapy.

Others

• Hocoma (DIH): Hocoma, part of DIH, is a global leader in robotic and sensor-based rehabilitation devices (Lokomat, Armeo). It is a broad incumbent in the robotics-based physical therapy category that overlaps with Sirica's robotic component.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat1 record

Key risks6 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sirica Therapeutics